scholarly journals THE ALCOHOL INDUSTRY HAS A CONFLICT OF INTEREST IN ALCOHOL RESEARCH AND POLICY

Addiction ◽  
2005 ◽  
Vol 100 (1) ◽  
pp. 128-129 ◽  
Author(s):  
Belinda Townsend ◽  
Mia Miller ◽  
Deborah Gleeson

Ralston et al highlight the ways that different actors in global nutrition governance conceptualise and frame the role of non-state actors in governance arrangements, including the potential for conflict of interest (COI) to undermine global health efforts. The authors argue that the World Health Organization (WHO) draft tool on managing COI in nutrition policy is an important innovation in global health, but that further research and refinement is needed for operationalising the management of COI with diverse actors in diverse contexts. In this commentary, reflecting on strategic framing and industry interference in policy-making, we argue for the urgent need for states and intergovernmental organisations to prevent alcohol industry interference in the development of national and global alcohol policy. We argue that policy incoherence remains a key barrier, where governments pursue health goals in the health sector while pursuing exports and market liberalisation of health harmful commodities in the trade sector.


2020 ◽  
Vol 110 (4) ◽  
pp. 485-488 ◽  
Author(s):  
Gemma Mitchell ◽  
Matthew Lesch ◽  
Jim McCambridge

The National Institutes of Health stopped the worldwide Moderate Alcohol and Cardiovascular Health (MACH) trial in 2018 because of institutional failings that led to the biased design of this major study. Drawing on e-mail correspondence among officials, researchers, and alcohol companies, we provide the first, to our knowledge, detailed analysis of alcohol industry involvement in the MACH trial. Alcohol companies agreed to fund the MACH trial to advance their commercial interests rather than to help answer a major scientific question. Alcohol industry executives seized opportunities presented by discussions of the MACH trial to try to influence this study and wider public health, research, and policy decision-making. The process of soliciting research funding from corporations, which included convincing alcohol companies that the study design supported their commercial interests, was intrinsically biased. Thus, the three parties—research funding officials, researchers, and industry executives—coproduced the biased trial design. A detailed understanding of this episode will be helpful in advancing efforts to protect public health research from biases associated with corporate donations.


ASHA Leader ◽  
2003 ◽  
Vol 8 (14) ◽  
pp. 25-25 ◽  
Author(s):  
Allan O. Diefendorf
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document